Although relatively small in the study cohorts, it does reveal a rather different staining pattern between the two groups, and specifically, tumours from African American patients is four-times likely to have reduced/loss of membranous ALCAM staining than that from the Caucasian patients, yet, the cytoplasmic staining of ALCAM does not differ between the two groups. The gene discussed is ALCAM; the disease is neoplasm.